Esomeprazole or omeprazole

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

InformationOmeprazole Omeprazole is a proton pump inhibitor that blocks H(+)-K(+)-ATPase , used to treat dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome.In vitroOmeprazole

The major metabolite of the gastric proton pump inhibitor, omeprazole produced by CYP3A4 sulfoxidation of esomeprazole.

The major metabolite of the gastric proton pump inhibitor, omeprazole produced by CYP3A4 sulfoxidation of esomeprazole.

The major metabolite of the gastric proton pump inhibitor, omeprazole produced by CYP3A4 sulfoxidation of esomeprazole.

The major metabolite of the gastric proton pump inhibitor, omeprazole produced by CYP3A4 sulfoxidation of esomeprazole.